The macular degeneration drug 'Vabysmo' is now available for prescription at general hospitals.

According to industry sources, Roche Korea’s Vabysmo (faricimab), the first bispecific antibody for ophthalmologic disease, has passed the drug committee (DC) of Big 5 tertiary general hospitals, including Samsung Medical Center in Seoul, Seoul National University Hospital, Seoul Asan Hospital, and Severance Hospital.

It is also available for prescription at medical centers specializing in ophthalmologic disease, including Konyang University Hospital, Kim’s Eye Hospital, Nune Eye Hospital, Inje University Busan Paik Hospital, and Chung-Ang University Healthcare System.

Vabys